BMK Pharma To Open $50M U.S. HQ and Pharmaceutical Facility in Allen

BMK Pharma said the facility—which will serve as a 503B compounding pharmacy and a sterile Contract Development and Manufacturing Organization—will be a testament to its commitment to advancing "Made in America" prescription medications and strengthening the U.S. pharmaceutical supply chain.

BMK Pharma has announced plans to open its U.S. headquarters in Allen. The 50,000-square-foot facility will serve as both a 503B compounding pharmacy and a sterile Contract Development and Manufacturing Organization (CDMO), producing injectable drugs and sterile dosage forms, the company said.

BMK said its Allen facility is expected to open in the third quarter of 2026. The company said the facility is a testament to BMK Pharma’s commitment to advancing “Made in America” prescription medications and strengthening the U.S. pharmaceutical supply chain.

BMK was founded by Frisco-based serial pharmaceutical entrepreneur Jay Bhaumik, who is also chairman of Thesis Pharma Ventures and president of DFW-based Proem Holding, which has a diversified real estate investment portfolio in medical office condo, multifamily, industrial and land development. Bhaumik was previously the CEO and managing partner at Frisco-based New Star Med Spa and the founder and CEO of Onexte Consulting, a cybersecurity consulting firm.

“We’re proud to launch BMK Pharma’s headquarters in Allen,” Bhaumik said in a statement. “Our mission is to ensure a reliable and innovative supply of sterile medicines, developed and manufactured right here in the United States. Allen provides the perfect environment, with access to exceptional talent and a strong community that supports innovation.”

Creating more than 100 ‘highly skilled jobs’

BMK said the new headquarters will create more than 100 highly skilled jobs in Allen, ranging from automation engineers and chemists to pharmacists and scientific researchers. A 503B compounding pharmacy, also known as an outsourcing facility, is a type of compounding pharmacy that compounds drugs on a larger scale than a traditional pharmacy. These facilities are federally regulated.

BMK Pharma said it chose Allen because of its business-friendly climate, highly educated workforce, and strategic support from the Allen Economic Development Corp.

“BMK Pharma’s decision to establish its headquarters here reflects Allen’s position as a growing hub for innovation and advanced manufacturing,” Allen EDC President Dan Bowman said in a statement. “This investment strengthens our local economy while reinforcing Allen’s reputation as a prime location for forward-thinking companies.”

In addition to pharmaceutical manufacturing, BMK said the facility will provide specialized expertise in sterile product development, partnering with pharmaceutical companies, biotech firms, and generic drug manufacturers. BMK Pharma said it seeks to become a trusted partner in advancing drug development and manufacturing solutions.


Don’t miss what’s next. Subscribe to Dallas Innovates.

Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.

One quick signup, and you’re done.

 

R E A D   N E X T

  • The inaugural three-day event lands in Dallas June 27–29 at Paul Quinn College, bringing together more than 40 speakers, curated activations, and a bold agenda built to move capital, spark deals, and support Black founders.

  • Launched in 1989 after its founders moved to North Texas, the family-owned theatrical and home entertainment distribution company has evolved alongside the film industry. It moved beyond DVDs and Blu-Ray discs to launch its proprietary streaming service, Hi-YAH!, which is dedicated to Asian action cinema—and also engages audiences through theatrical runs and film festivals.

  • The southern half of Dallas County is home to just over 1.05 million residents. That’s about 40% of the total number of people who call Dallas County home—and roughly 200,000 more than the entire population of San Francisco. Coupled with the fact that Dallas-Fort Worth is emerging as a top life science market, as documented in a 2023 CBRE report, you can see why the DeSoto Development Corp. is including an 80-acre Life Sciences Innovation Core among its major projects. “In terms of economic development, research shows that it’s more effective when it happens regionally,” says Matt Carlson, DDC's chief…

  • Qualthera, a new company founded by entrepreneur Donald Prentiss, has made its first acquisition—Central Drug in Victoria, Texas—and set its sights on Dallas for its second. Prentiss sees an opportunity in the shifting pharmacy landscape, where changes, including downsizing by large chains, have created service gaps that independent pharmacies could fill.

  • The owners of U.S. Property Development have been involved in more than $50 million in projects over the past 18 months, the new firm said. It's owned by investment leaders behind Fort Worth-based U.S. Energy Development Corp., and leverages operational efficiencies from a shared back-office platform.